secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001193125-25-273217
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar posts corporate deck; no material new facts in filed excerpt
--------------------------------------------------------------------

- Larimar posted an updated corporate presentation on its website on November 10, 2025.
- Presentation is intended for investor and analyst meetings; no specific updates provided.
- Filed excerpt contains only the title slide; substantive content not available.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000119312525273217/0001193125-25-273217-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000119312525273217/lrmr-20251110.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-273217

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer